Search

everythinglearnresearchcommunity

for

Search:↓

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.

New compounds show promise as nonsteroidal treatments for hair loss.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

The methods accurately measured brain androgens, showing most 5α-androstane-3α,17β-diol comes from outside the brain, while androsterone is both transported and made in the brain.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

A rigid compound with a common structural motif was successfully synthesized.

3-tetrazolo steroidal analogs can strongly inhibit the enzyme linked to hair loss.

Cyproterone acetate effectively treats virilized women, especially under 35, despite some side effects.

Chlormadinone acetate is useful for birth control and treating various hormonal issues.

The new method improves finasteride's effectiveness for hair loss treatment.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

The new method makes finasteride cheaper and easier to produce.

A yeast-based test can detect the steroid methyltestosterone in urine longer than traditional methods.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.

A genetic defect causes males in some Mediterranean populations to be born with ambiguous genitalia and develop male traits at puberty.

Certain chemical changes to cortisol and progesterone can increase or decrease their ability to inhibit hair growth.

The conclusion is that tritium-labeled testosterone metabolites can be made and are better converted into dihydrotestosterone in skin cells than in prostate tissue.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

New testosterone analogs show promise for male contraception with better activity and potentially fewer side effects.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

New steroid derivatives show promise as anticancer agents, even against resistant cells.

Compound 4 is a promising treatment for hair loss with low toxicity.

GI197111X is best dissolved in Capmul MCM for trials.

A woman's hair loss and other symptoms were due to a rare hormone deficiency treatable with steroids.

The study found that urine metabolites M1b or M4 are the best indicators of ATD use in horses, with detection possible up to 77 hours in urine and 28 hours in blood.

Researchers created a new method to measure brain steroids, finding higher levels of certain steroids and changes due to a drug.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Human liver enzyme DHEA ST helps process minoxidil.